Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry.


Journal

American journal of hematology
ISSN: 1096-8652
Titre abrégé: Am J Hematol
Pays: United States
ID NLM: 7610369

Informations de publication

Date de publication:
02 2019
Historique:
received: 22 09 2018
revised: 27 10 2018
accepted: 12 11 2018
pubmed: 21 11 2018
medline: 26 11 2019
entrez: 21 11 2018
Statut: ppublish

Résumé

Autoimmune neutropenia of infancy (AIN) is characterized by low risk of severe infection, tendency to spontaneously resolve and typically onset at ≤4-5 years of age; it is due to auto-antibodies whose detection is often difficult. In case of negativity of 4 antineutrophils autoantibody tests, after having excluded ethnic, postinfection, drug induced, or congenital neutropenia, according to the Italian guidelines the patients will be defined as affected by "idiopathic neutropenia" (IN). We describe the characteristics of 85 IN patients enrolled in the Italian neutropenia registry: they were compared with 336 children affected by AIN. The 2 groups were clinically very similar and the main differences were detection age (later in IN), length of disease (longer in IN) and, among recovered patients, age of spontaneous recovery: the median age at resolution was 2.13 years in AINs and 3.03 years in INs (P = .00002). At bivariate analysis among AIN patients earlier detection age (P = .00013), male sex (P = .000748), absence of leucopenia (P = .0045), and absence of monocytosis (P = .0419) were significantly associated with earlier recovery; in the IN group only detection age (P = .013) and absence of monocytosis (P = .0333) were significant. At multivariate analysis detection age and absence of monocytosis were independently significant (P = 6.7e-05 and 4.4e-03, respectively) in the AIN group, whereas in the IN group only detection age stayed significant (P = .013).

Identifiants

pubmed: 30456824
doi: 10.1002/ajh.25353
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

216-222

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Piero Farruggia (P)

Pediatric Hematology and Oncology Unit, A.R.N.A.S. Ospedale Civico, Palermo, Italy.

Francesca Fioredda (F)

Clinical and Experimental Unit G. Gaslini Children's Hospital, Genoa, Italy.

Giuseppe Puccio (G)

Department of Sciences for Health Promotion, University of Palermo, Palermo, Italy.

Daniela Onofrillo (D)

Pediatric Hematology and Oncology Unit, Department of Hematology, Spirito Santo Hospital, Pescara, Italy.

Giovanna Russo (G)

Pediatric Hematology and Oncology Unit, Azienda Policlinico-Vittorio Emanuele, University of Catania, Catania, Italy.

Angelica Barone (A)

Department of Pediatric Onco-Hematology, University Hospital, Parma, Italy.

Sonia Bonanomi (S)

MBBM Foundation, Department of Pediatrics, University of Milano - Bicocca, Monza, Italy.

Gianluca Boscarol (G)

Department of Pediatrics, Central Teaching Hospital Bolzano, Bolzano, Italy.

Andrea Finocchi (A)

University of Rome Tor Vergata, Rome, Italy.

Roberta Ghilardi (R)

Department of Pediatrics, Ospedale Maggiore Policlinico IRCCS, Milan, Italy.

Paola Giordano (P)

Department of Biomedical Sciences and Human Oncology, Pediatric Section, University "A. Moro" of Bari, Bari, Italy.

Saverio Ladogana (S)

Department of Hematology, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.

Giuseppe Lassandro (G)

Department of Biomedical Sciences and Human Oncology, Pediatric Section, University "A. Moro" of Bari, Bari, Italy.

Laura Luti (L)

Pediatric Hematology Oncology, Bone Marrow Transplant, Azienda Ospedaliero Universitaria Pisana, S. Chiara Hospital, Pisa, Italy.

Tiziana Lanza (T)

Clinical and Experimental Unit G. Gaslini Children's Hospital, Genoa, Italy.

Rosalba Mandaglio (R)

Pugliese-Ciaccio Hospital, Catanzaro, Italy.

Nicoletta Marra (N)

A.O.R.N. Santobono Pausillipon, Naples, Italy.

Baldassare Martire (B)

Pediatric Science and Surgery Department, Pediatric Onco-Hematology Unit, Hospital Policlinico- Giovanni XXIII, Bari, Italy.

Elena Mastrodicasa (E)

Pediatric Oncology Hematology Unit, S. Maria Della Misericordia Hospital, Perugia, Italy.

Milena Motta (M)

Pediatric Hematology and Oncology Unit, Azienda Policlinico-Vittorio Emanuele, University of Catania, Catania, Italy.

Lucia Dora Notarangelo (LD)

Onco-Haematology and Bone Marrow Transplantation Unit, Children's Hospital, Brescia, Italy.

Marta Pillon (M)

Pediatric Onco-Hematology Department, University of Padova, Padova.

Laura Porretti (L)

Flow Cytometry Service, Laboratory of Clinical Chemistry and Microbiology, IRCCS "Ca' Granda" Foundation, Maggiore Hospital Policlinico, Milan, Italy.

Jessica Serafinelli (J)

University of Rome Tor Vergata, Rome, Italy.

Angela Trizzino (A)

Pediatric Hematology and Oncology Unit, A.R.N.A.S. Ospedale Civico, Palermo, Italy.

Fabio Tucci (F)

Department of Pediatric Onco-Hematology, Meyer Children's Hospital, Florence, Italy.

Marinella Veltroni (M)

Department of Pediatric Onco-Hematology, Meyer Children's Hospital, Florence, Italy.

Federico Verzegnassi (F)

Institute for Maternal and Child Health (I.R.C.C.S) Burlo Garofolo, Trieste, Italy.

Ugo Ramenghi (U)

Department of Pediatric and Public Health Sciences, University of Torino, Italy.

Carlo Dufour (C)

Clinical and Experimental Unit G. Gaslini Children's Hospital, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH